CN105121633A - 一种建立神经上皮干细胞的培养基、方法及其应用 - Google Patents
一种建立神经上皮干细胞的培养基、方法及其应用 Download PDFInfo
- Publication number
- CN105121633A CN105121633A CN201480002707.4A CN201480002707A CN105121633A CN 105121633 A CN105121633 A CN 105121633A CN 201480002707 A CN201480002707 A CN 201480002707A CN 105121633 A CN105121633 A CN 105121633A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- neuroepithelial stem
- cell
- culture medium
- neuroepithelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 161
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000004069 differentiation Effects 0.000 claims abstract description 33
- 210000004027 cell Anatomy 0.000 claims description 78
- 239000001963 growth medium Substances 0.000 claims description 52
- 230000003321 amplification Effects 0.000 claims description 47
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 47
- 239000003112 inhibitor Substances 0.000 claims description 38
- 210000002569 neuron Anatomy 0.000 claims description 37
- 230000001537 neural effect Effects 0.000 claims description 34
- 210000005036 nerve Anatomy 0.000 claims description 32
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 23
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 23
- 239000000654 additive Substances 0.000 claims description 23
- 239000006160 differential media Substances 0.000 claims description 19
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 15
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 15
- 210000000981 epithelium Anatomy 0.000 claims description 15
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 15
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical group CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 claims description 14
- 102000001267 GSK3 Human genes 0.000 claims description 14
- 108060006662 GSK3 Proteins 0.000 claims description 14
- 239000012190 activator Substances 0.000 claims description 14
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 claims description 14
- 238000001338 self-assembly Methods 0.000 claims description 14
- 238000002965 ELISA Methods 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- CDOVNWNANFFLFJ-UHFFFAOYSA-N 4-[6-[4-(1-piperazinyl)phenyl]-3-pyrazolo[1,5-a]pyrimidinyl]quinoline Chemical compound C1CNCCN1C1=CC=C(C2=CN3N=CC(=C3N=C2)C=2C3=CC=CC=C3N=CC=2)C=C1 CDOVNWNANFFLFJ-UHFFFAOYSA-N 0.000 claims description 9
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 claims description 9
- 102100034111 Activin receptor type-1 Human genes 0.000 claims description 8
- 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 claims description 8
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 claims description 8
- 101000934638 Homo sapiens Bone morphogenetic protein receptor type-1A Proteins 0.000 claims description 8
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical group C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 claims description 8
- 230000001629 suppression Effects 0.000 claims description 8
- 102000029816 Collagenase Human genes 0.000 claims description 6
- 108060005980 Collagenase Proteins 0.000 claims description 6
- 229960002424 collagenase Drugs 0.000 claims description 6
- 238000009256 replacement therapy Methods 0.000 claims description 6
- 230000019491 signal transduction Effects 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 5
- 230000001079 digestive effect Effects 0.000 claims description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 5
- 230000007246 mechanism Effects 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 108010019160 Pancreatin Proteins 0.000 claims description 4
- 210000000461 neuroepithelial cell Anatomy 0.000 claims description 4
- 229940055695 pancreatin Drugs 0.000 claims description 4
- 238000004114 suspension culture Methods 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 230000004031 neuronal differentiation Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract description 5
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000010276 construction Methods 0.000 description 18
- 230000007774 longterm Effects 0.000 description 14
- 210000001178 neural stem cell Anatomy 0.000 description 14
- 239000002243 precursor Substances 0.000 description 14
- 230000002518 glial effect Effects 0.000 description 11
- 230000005855 radiation Effects 0.000 description 10
- 108010088225 Nestin Proteins 0.000 description 8
- 102000008730 Nestin Human genes 0.000 description 8
- 210000005055 nestin Anatomy 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 210000002242 embryoid body Anatomy 0.000 description 7
- 108091008794 FGF receptors Proteins 0.000 description 6
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 6
- 210000003710 cerebral cortex Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 5
- 101150081664 PAX6 gene Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000024245 cell differentiation Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 3
- 102000000905 Cadherin Human genes 0.000 description 3
- 108050007957 Cadherin Proteins 0.000 description 3
- 108050000637 N-cadherin Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000029454 interkinetic nuclear migration Effects 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 2
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 2
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 2
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
- 101000941893 Felis catus Leucine-rich repeat and calponin homology domain-containing protein 1 Proteins 0.000 description 1
- 101000888214 Flaveria pringlei Serine hydroxymethyltransferase 1, mitochondrial Proteins 0.000 description 1
- 101001013648 Homo sapiens Methionine synthase Proteins 0.000 description 1
- 101001116314 Homo sapiens Methionine synthase reductase Proteins 0.000 description 1
- 101001040808 Homo sapiens Serine hydroxymethyltransferase, cytosolic Proteins 0.000 description 1
- 102100031551 Methionine synthase Human genes 0.000 description 1
- 102100024614 Methionine synthase reductase Human genes 0.000 description 1
- 102100025394 Monofunctional C1-tetrahydrofolate synthase, mitochondrial Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
- 101001030849 Rhinella marina Mesotocin receptor Proteins 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 102100021225 Serine hydroxymethyltransferase, cytosolic Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 108010022790 formyl-methenyl-methylenetetrahydrofolate synthetase Proteins 0.000 description 1
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 101150027852 pou3f2 gene Proteins 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000857 visual cortex Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
提供一种建立神经上皮干细胞的培养基、方法及其应用。所述培养基包括用于将多能干细胞诱导分化为初级神经上皮干细胞的分化培养基及用于使初级神经上皮干细胞扩增的扩增培养基。
Description
PCT国内申请，说明书已公开。
Claims (10)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2014/074029 WO2015143622A1 (zh) | 2014-03-25 | 2014-03-25 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105121633A true CN105121633A (zh) | 2015-12-02 |
| CN105121633B CN105121633B (zh) | 2018-05-01 |
Family
ID=54193865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480002707.4A Active CN105121633B (zh) | 2014-03-25 | 2014-03-25 | 一种建立神经上皮干细胞的培养基、方法及其应用 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20160251612A1 (zh) |
| CN (1) | CN105121633B (zh) |
| WO (1) | WO2015143622A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113403262A (zh) * | 2021-06-23 | 2021-09-17 | 昆明理工大学 | 一种对食蟹猴干细胞的无饲养层培养方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010096496A2 (en) | 2009-02-17 | 2010-08-26 | Memorial Sloan-Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
| WO2013067362A1 (en) | 2011-11-04 | 2013-05-10 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (da) neurons for engraftment |
| EP3498824A1 (en) | 2013-04-26 | 2019-06-19 | Memorial Sloan-Kettering Cancer Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010144696A1 (en) * | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
| WO2011149762A2 (en) * | 2010-05-25 | 2011-12-01 | Memorial Sloan-Kettering Cancer Center | Method of nociceptor differentiantion of human embryonic stem cells and uses thereof |
| WO2013067362A1 (en) * | 2011-11-04 | 2013-05-10 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (da) neurons for engraftment |
| CN103160466A (zh) * | 2011-12-14 | 2013-06-19 | 中兴大学 | 由万能干细胞所分化的神经上皮细胞的培养方法及培养基 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102191221B (zh) * | 2010-03-17 | 2014-11-19 | 中国人民解放军第二军医大学东方肝胆外科医院 | 一种能无限自我更新的神经干细胞、其制备方法及其用途 |
-
2014
- 2014-03-25 WO PCT/CN2014/074029 patent/WO2015143622A1/zh active Application Filing
- 2014-03-25 CN CN201480002707.4A patent/CN105121633B/zh active Active
- 2014-03-25 US US14/770,283 patent/US20160251612A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010144696A1 (en) * | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
| WO2011149762A2 (en) * | 2010-05-25 | 2011-12-01 | Memorial Sloan-Kettering Cancer Center | Method of nociceptor differentiantion of human embryonic stem cells and uses thereof |
| WO2013067362A1 (en) * | 2011-11-04 | 2013-05-10 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (da) neurons for engraftment |
| CN103160466A (zh) * | 2011-12-14 | 2013-06-19 | 中兴大学 | 由万能干细胞所分化的神经上皮细胞的培养方法及培养基 |
Non-Patent Citations (1)
| Title |
|---|
| 刘建新等: "白血病抑制因子对体外培养神经干细胞影响的试验研究", 《国际检验医学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113403262A (zh) * | 2021-06-23 | 2021-09-17 | 昆明理工大学 | 一种对食蟹猴干细胞的无饲养层培养方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105121633B (zh) | 2018-05-01 |
| US20160251612A1 (en) | 2016-09-01 |
| WO2015143622A1 (zh) | 2015-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Doi et al. | Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation | |
| Kelava et al. | Stem cell models of human brain development | |
| Li et al. | Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons | |
| Dupin et al. | Isolation and differentiation properties of neural crest stem cells | |
| JP2022037214A (ja) | ヒト胚性幹細胞の侵害受容器分化のための方法およびその使用 | |
| CN104894060B (zh) | 诱导体细胞转分化为神经干细胞的方法及其应用 | |
| JP2022078245A (ja) | 多能性細胞を分化させるための方法 | |
| CN105940101A (zh) | 由人多能干细胞特化功能性颅基板衍生物 | |
| Thier et al. | Identification of embryonic neural plate border stem cells and their generation by direct reprogramming from adult human blood cells | |
| JP6824267B2 (ja) | ヒト誘導多能性幹細胞からライディッヒ細胞への分化誘導方法及びその用途 | |
| JP2017511153A (ja) | 中脳ドーパミン作動性ニューロンの生産およびその使用方法 | |
| US10724000B2 (en) | Small molecule based conversion of somatic cells into neural crest cells | |
| CN103834613B (zh) | 制备多能心血管前体细胞及维持其心血管分化能力的方法 | |
| CN105121633A (zh) | 一种建立神经上皮干细胞的培养基、方法及其应用 | |
| Pacherník et al. | Neural differentiation of mouse embryonic stem cells grown in monolayer | |
| CN106337037A (zh) | 一种诱导成纤维细胞直接向神经细胞转化的药物组合物及其用途 | |
| Kumar et al. | Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells | |
| JP2023551851A (ja) | 胚性幹細胞または人工多能性幹細胞からの神経前駆細胞の作製 | |
| CN110872576A (zh) | 一种将小鼠成纤维细胞转分化为多巴胺能神经元的方法 | |
| Li et al. | Engraftable neural crest stem cells derived from cynomolgus monkey embryonic stem cells | |
| CN105420193B (zh) | 分化培养基及其在制备神经干细胞中的用途 | |
| Loffet et al. | Pluripotent stem cell derived intestinal organoids with an enteric nervous system | |
| Baizabal et al. | The embryonic midbrain directs neuronal specification of embryonic stem cells at early stages of differentiation | |
| Weed et al. | Strategies for retinal cell generation from human pluripotent stem cells | |
| Kim et al. | Direct conversion of human umbilical cord blood into induced neural stem cells with SOX2 and HMGA2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240102 Address after: 650051 new welcome campus, Kunming University of Science and Technology, 50 East Ring Road, Yunnan, Kunming Patentee after: Kunming University of Technology Asset Management Co.,Ltd. Address before: No.8 Xitao Road, Kunming Economic Development Zone, Yunnan Province, 650000 Patentee before: YUNNAN KEY LAB OF PRIMATE BIOMEDICINE RESEARCH |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240321 Address after: Room 9320, National Science and Technology Entrepreneurship Building, Kunming University of Technology, No. 296 Xuefu Road, Kunming City, Yunnan Province, 650051 Patentee after: Kunming Yuanmeng Life Science Research Institute Co.,Ltd. Country or region after: Zhong Guo Address before: 650051 new welcome campus, Kunming University of Science and Technology, 50 East Ring Road, Yunnan, Kunming Patentee before: Kunming University of Technology Asset Management Co.,Ltd. |
|
| TR01 | Transfer of patent right |